Societal CDMO Announces Closing of $8.3 Million Public Offering of Common Stock
August 29, 2023 07:00 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving...
Societal CDMO Announces Pricing of $8.3 Million Public Offering of Common Stock
August 24, 2023 07:30 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving...
Societal CDMO Announces Appointment of Matt Arens to Board of Directors
August 23, 2023 16:04 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...
Societal CDMO Announces Proposed Public Offering of Common Stock
August 23, 2023 16:04 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (“CDMO”) dedicated to solving...
Societal CDMO Reports Second Quarter 2023 Financial Results
August 14, 2023 16:05 ET
|
Societal CDMO, Inc.
Recorded Q2 Revenue of $21.8 Million Signed Multiple New Business Agreements with New and Existing Customers Secured Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement...
Societal CDMO Reschedules Second Quarter 2023 Financial Results Reporting to August 14, 2023
August 09, 2023 07:00 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
August 02, 2023 16:05 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
July 26, 2023 07:00 ET
|
Societal CDMO, Inc.
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25 Years of Manufacturing of Schedule 2 Products No Additional Investment Required to...
Societal CDMO Selected by Spinnaker Biosciences to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate
July 10, 2023 07:00 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 10, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Societal CDMO Reports Inducement Grants for New Staff
July 07, 2023 16:05 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 07, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...